‘World-leading’: RSV vaccine free for pregnant women from 2025
The RSV vaccine Abrysvo costs more than $300 on the private market.
Pregnant women can access respiratory syncytial virus vaccination under the National Immunisation Program starting next winter, the Federal Government has announced.
Single-dose respiratory syncytial virus (RSV) vaccine Abrysvo is recommended for women at 28-36 weeks of pregnancy but costs more than $300 on the private market.
